Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cecilia Bartoli
Observed name:
C Bartoli
Institutions:
Menarini Group (Luxembourg),
Menarini Group (Italy),
Menarini Group (Germany)
Observed institutions:
Boston Scientific (United States),
Menarini Group (Luxembourg),
Menarini Group (Italy),
Ospedale Versilia,
Menarini Group (Germany),
Azienda USL Toscana Nord Ovest
show all 6
ORCID:
0009-0001-5911-4542
Observed ORCID:
0009-0001-5911-4542
OpenAlex ID:
A5014422246
Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice
2021
·
Leonardo Calò
, Valter Bianchi
, et al.
·
Circulation Heart Failure
·
53
Probiotic Yeasts and Bacteria: A Complementary Approach to Gut Health
2026
·
Arrigo F. G. Cicero
, Cecilia Bartoli
, et al.
·
Microorganisms
·
2
Primary care and specialist physicians’ prescribing preferences for concurrent probiotic-antibiotic therapy: a multinational clinical practice survey across 13 countries
2025
·
Stephan R. Vavricka
, Cecilia Bartoli
, et al.
·
Frontiers in Medicine
·
2
PDF
Physician attitudes toward natural syrup formulations for cough and sore throat: a multinational cross-sectional survey of 398 healthcare professionals across 13 countries
2026
·
Barbara LePetri
, Cecilia Bartoli
, et al.
·
Frontiers in Pharmacology
·
1
PDF
Physician Preferences and Prescribing Patterns for Hypertonic and Isotonic Saline Solutions in Upper Respiratory Symptom Management: A Multinational Clinical Practice Survey Across 13 Countries
2025
·
Giorgio W Canonica
, Carolina Castillo
, et al.
·
Cureus
·
1
PDF
P228 Wearable Defibrillator in Clinical Practice. Multiannual Multi–center Experience
2022
·
G Solarino
, C Bartoli
, et al.
·
European Heart Journal Supplements
Show more works
View as search
Works count:
6
Citation count:
59
H-index:
2
I10-index:
1
Year
Topic
Type